A Study of LY3478006 in Healthy Participants

NCT04230122 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Protocol stopping criteria (safety) were met.

Conditions

Healthy

Interventions

DRUG: LY3478006 - IV
DRUG: LY3478006 - SC
DRUG: Placebo - IV
DRUG: Placebo - SC

Sponsor

Eli Lilly and Company